Firm |
Deal |
Value |
Client |
Lawyer(s) involved |
Davis Polk |
Philippine Long Distance Telephone Co sale of BPO business owned by its subsidiary SPi Global Holdings, Inc to an acquisition vehicle controlled by CVC Capital Partners |
|
Philippine Long Distance Telephone Co |
Mark J.Lehmkuhler, John D. Paton (Partners), Sam Kelso, Randy Samson (Associates) |
Davis Polk |
CNOOC’s proposed acquisition of Nexen |
$15.1 billion |
CNOOC Ltd |
George R. Bason Jr, Howard Zhang, Leonard Kreynin, Kirtee Kapoor, John B. Reynolds III, Paul Chow, Antony Dapiran (Partners), James E. Elworth, Brian J. Snyder (Associates) |
Hogan Lovells |
Kingdom Holding Co’s acquisition of strategic stake in the largest internet consumer sales company in China, 360Buy Jingdong Inc |
$400 million |
Kingdom Holding Co |
Mark Mazo, Steven Robinson, Colin Craik (Partners), Lu Zhou (Senior associate) |
Kirkland & Ellis International (U.S. counsel) |
China Nuokang Bio-pharmaceutical Inc’s merger with Kingbird Mergerco. Inc, a wholly-owned subsidiary of Kingbird Investment Inc |
$43.4 million |
The buyer group |
David Zhang, Stephanie Tang, Jesse Sheley (Partners), Siwei Chen, Julia Yu, Steve Lin (Associates) |
Maples and Calder (Cayman Islands legal counsel) |
China Nuokang Bio-pharmaceutical Inc’s merger with Kingbird Mergerco. Inc, a wholly-owned subsidiary of Kingbird Investment Inc |
$43.4 million |
China Nuokang Bio-pharmaceutical Inc |
Jenny Nip (Partner) |
Paul Hastings |
Global depositary receipts (GDRs) offering by Seoul-headquartered Youngone Corp |
$114 million |
Bookrunner – Credit Suisse |
Dong Chul Kim (Counsel), Steve Kang, Jared Lee (Associates) |
Paul Hastings |
Lotte Shopping’s equity-linked bond |
$303 million |
Lead arrangers |
Daniel Kim, David Grimm and Steven Winegar (Partners), Steve Kang (Associate) |
Skadden, Arps, Slate, Meagher & Flom (U.S. counsel) |
China Nuokang Bio-pharmaceutical Inc’s merger with Kingbird Mergerco. Inc, a wholly-owned subsidiary of Kingbird Investment Inc |
$43.4 million |
Independent Committee of China Nuokang Bio-pharmaceutical Inc |
Peter Huang (Partner), Olivia Odell, Ning Dong (Associates) |
Where exact value is not known, ALB will use an approximate value based on available market data or coverage.
Follow us on Twitter: @ALB_Magazine.